Xcout Intel
Primogene
Primogene GmbH is a biotechnology startup founded in 2023 and based in Leipzig, Germany. Backed by venture funding, the company develops nature-inspired biological solutions and products.
Subscribe to see Primogene’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Primogene at a glance
Primogene is a biotechnology company headquartered in Germany. Its most recent funding round, Seed, raised $4.1M in April 2026. Xcout tracks 3 named people at Primogene, including Dr.-Ing. Reza Mahour (CEO and Co-founder).
Primogene leadership
- Dr.-Ing. Reza MahourCEO and Co-founder
- Linda KargerCOO and Co-founder
- Valerian GroteCo-founder
Primogene funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $4.1M | 10 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Primogene competitors
A few of Primogene's closest competitors — see the full list of competitors and alternatives →
Navigo Proteins GmbH is a biotechnology research company headquartered in Halle, Germany, specializing in precision protein engineering for life sciences. The firm develops engineered affinity proteins and tailored solutions for biopharmaceutical applications.
Prime Life Sciences is a biotechnology company specialized in pharmacy, biotechnology, and medical devices. Launched in 2020, it is headquartered in Basel, Switzerland, delivering targeted solutions across various healthcare sectors.
VITA 34 AG is dedicated to the collection, processing, and long-term storage of stem cells derived from umbilical cord blood and tissue. Its operations span Germany, Spain, and global markets. The company actively develops a range of advanced therapeutic solutions, including cell and gene therapies, specialized cell therapeutic procedures, cryopreservation of a patient's own immune cells, and CAR-T cell technology. Furthermore, VITA 34 manufactures advanced therapy medicinal products (ATMPs) based on mesenchymal stem cells for experimental applications by specialized medical institutions. It also preserves stem cells from perinatal tissues and adult body fat, and provides contract manufacturing for pharmaceutical intermediates. Founded in 1997, VITA 34 AG is headquartered in Leipzig, Germany.
Epitome Therapeutics is an early-stage biotechnology company based in Vienna, Austria, founded in 2025 as a spin-off from EMBL Rome. It is developing a new therapeutic modality for precise and durable activation of endogenous genes.
Cocoon Biotech, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts. The company operates as a biotechnology firm focused on developing innovative biological solutions.
Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.
Get Primogene's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Primogene in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access